False negative tests in breast cancer may lead to wrong drug choice
A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified ...
Jun 27, 2011
0
0